+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Drug Development"

From
From
From
From
From
From
From
From
From
Top 6 Growth Opportunities in Pharma-Biotech, 2025 - Product Thumbnail Image

Top 6 Growth Opportunities in Pharma-Biotech, 2025

  • Report
  • February 2025
  • Global
From
From
From
From
From
From
Compound Management - Global Strategic Business Report - Product Thumbnail Image

Compound Management - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
From
From
ADME-Toxicology Testing - Global Strategic Business Report - Product Thumbnail Image

ADME-Toxicology Testing - Global Strategic Business Report

  • Report
  • April 2025
  • 472 Pages
  • Global
From
Orphan Drugs - Global Strategic Business Report - Product Thumbnail Image

Orphan Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 409 Pages
  • Global
From
Loading Indicator

The Drug Development market within the context of Biotechnology is a highly competitive and complex industry. It involves the research, development, and commercialization of new drugs and treatments for a variety of diseases and conditions. This process requires a significant amount of resources, including capital, personnel, and technology. The development of a new drug or treatment typically involves a long and expensive process of clinical trials and regulatory approval. The Drug Development market is a major component of the biotechnology industry, and is a key driver of innovation and economic growth. It is also a major source of employment, with many companies employing thousands of people in research and development, manufacturing, and marketing. Some of the major companies in the Drug Development market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Johnson & Johnson. Other notable companies include AstraZeneca, Sanofi, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more